Ischemic heart disease decisions — 2012

The Veteran's appeal for a total disability rating based on individual unemployability (TDIU) has been denied as he is not shown to be unable to secure or follow substantially gainful employment due to his service-connected disabilities.

The Board found that the Veteran's heart disability was not caused by VA carelessness, negligence, or lack of proper skill. The delay in treatment for a cardiac condition was reasonable given the initial diagnosis of pneumonia.

The Veteran's appeal is being remanded to the RO for a video-conference hearing before the Board at the RO. The issues of entitlement to increased evaluations for various conditions are still pending.

The Veteran's unauthorized medical expenses incurred on April 25, 2008 at Memorial Hospital were not authorized by VA and did not meet the criteria for reimbursement under applicable laws.

The Board has determined that the severance of service connection for coronary artery disease was not proper and must be restored.

The Board has remanded the case for additional development, including obtaining medical records and clarifying whether ablation procedures were conducted at a VA or private facility.

The Veteran is seeking compensation under 38 U.S.C.A. § 1151 for additional disability to include a heart disorder due to VA medical treatment from May 1997 to June 1997 for subacute bacterial endocarditis Streptococcus sanguis. The Board has determined that further development is needed, including obtaining private medical records and reviewing the claims file.

The Veteran's appeal was denied for various conditions and claims, including those related to his knee replacements, ankle disorders, carotid stenosis, and right leg wounds. The appeals were addressed in the context of rating decisions and effective dates.

The Board has decided to remand the claims for further development due to insufficient evidence regarding service connection and exposure to asbestos.

The Board has granted service connection for prostate cancer, coronary artery disease, and left knee disorder as secondary to presumed in-service herbicide exposure.

The Board has determined that additional development is needed, including obtaining service clinical hospital records and post-service medical reports. The Veteran should be asked to provide information about his alleged hospitalization during service and any treatment since discharge.

The Veteran's appeal is being remanded due to the need for additional development, including VA examinations for his claimed heart disability, hemorrhoids, and left foot disability.

The Board has dismissed the appeal due to the death of the appellant.

The Board has reviewed the evidence and finds that none of the Veteran's claimed conditions are related to his service, including any exposure to ionizing radiation. As such, service connection for loss of teeth, blindness, brittle bones, a heart disorder, and shortness of breath is denied.

The Veteran's claim for compensation benefits under 38 U.S.C.A. § 1151 for additional coronary artery disease due to treatment at a VA facility was denied as there is no evidence of carelessness, negligence, or fault on the part of VA.

The Veteran's claims are being remanded for additional development, including VA examinations and review of the claims file.

The case is being remanded for further development and review of the claims, including obtaining additional VA treatment records and SSA disability benefit documents.

The Board has granted service connection for ischemic heart disease and the cause of death due to coronary artery disease, both presumed to be related to Agent Orange exposure during service.

The Board denied the Veteran's claims for service connection for left ankle disability, bilateral hearing loss disability, diabetes mellitus, and heart condition. The appeals were based on direct service connection.

The Veteran's service-connected PTSD did not cause or contribute substantially to his death due to colon cancer, hypertension, arteriosclerotic heart disease, and congestive heart failure.